Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Production and characterization of novel ssRNA bacteriophage virus-like particles from metagenomic sequencing data.

Liekniņa I, Kalniņš G, Akopjana I, Bogans J, Šišovs M, Jansons J, Rūmnieks J, Tārs K.

J Nanobiotechnology. 2019 May 13;17(1):61. doi: 10.1186/s12951-019-0497-8.

2.

Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.

Kazaks A, Lu IN, Farinelle S, Ramirez A, Crescente V, Blaha B, Ogonah O, Mukhopadhyay T, de Obanos MP, Krimer A, Akopjana I, Bogans J, Ose V, Kirsteina A, Kazaka T, Stonehouse NJ, Rowlands DJ, Muller CP, Tars K, Rosenberg WM.

BMC Biotechnol. 2017 Nov 10;17(1):79. doi: 10.1186/s12896-017-0396-8.

3.

Structural characterization of cevimeline and its trans-impurity by single crystal XRD.

Stepanovs D, Tetere Z, Rāviņa I, Kumpiņš V, Zicāne D, Bizdēna Ē, Bogans J, Novosjolova I, Grigaloviča A, Meri RM, Fotins J, Čerkasovs M, Mishnev A, Turks M.

J Pharm Biomed Anal. 2016 Jan 25;118:404-409. doi: 10.1016/j.jpba.2015.11.006. Epub 2015 Nov 14.

PMID:
26609680
4.

Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.

Strods A, Ose V, Bogans J, Cielens I, Kalnins G, Radovica I, Kazaks A, Pumpens P, Renhofa R.

Sci Rep. 2015 Jun 26;5:11639. doi: 10.1038/srep11639.

5.

Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.

Skrastina D, Petrovskis I, Lieknina I, Bogans J, Renhofa R, Ose V, Dishlers A, Dekhtyar Y, Pumpens P.

PLoS One. 2014 Dec 1;9(12):e114006. doi: 10.1371/journal.pone.0114006. eCollection 2014.

6.

Structural characterization of CspZ, a complement regulator factor H and FHL-1 binding protein from Borrelia burgdorferi.

Brangulis K, Petrovskis I, Kazaks A, Bogans J, Otikovs M, Jaudzems K, Ranka R, Tars K.

FEBS J. 2014 Jun;281(11):2613-22. doi: 10.1111/febs.12808. Epub 2014 Apr 28.

7.

Mosaic RNA phage VLPs carrying domain III of the West Nile virus E protein.

Cielens I, Jackevica L, Strods A, Kazaks A, Ose V, Bogans J, Pumpens P, Renhofa R.

Mol Biotechnol. 2014 May;56(5):459-69. doi: 10.1007/s12033-014-9743-3.

PMID:
24570176
8.

Chimeric derivatives of hepatitis B virus core particles carrying major epitopes of the rubella virus E1 glycoprotein.

Skrastina D, Petrovskis I, Petraityte R, Sominskaya I, Ose V, Lieknina I, Bogans J, Sasnauskas K, Pumpens P.

Clin Vaccine Immunol. 2013 Nov;20(11):1719-28. doi: 10.1128/CVI.00533-13. Epub 2013 Sep 4.

9.

Fibronectin-binding nanoparticles for intracellular targeting addressed by B. burgdorferi BBK32 protein fragments.

Ranka R, Petrovskis I, Sominskaya I, Bogans J, Bruvere R, Akopjana I, Ose V, Timofejeva I, Brangulis K, Pumpens P, Baumanis V.

Nanomedicine. 2013 Jan;9(1):65-73. doi: 10.1016/j.nano.2012.05.003. Epub 2012 May 23.

PMID:
22633898

Supplemental Content

Loading ...
Support Center